SPT GEN LIF PA Partex.AI Rare Disease Therapeutics: 2025 Deal Trends and Outlook Executive Summary The global rare-disease treatment landscape is rapidly evolving, driven by strong therapy pipelines, regulatory support…
ART BIO TCH MED GEN PA Partex.AI The Unified Biosystem for Drug Discovery In 2026, the biggest constraint in pharmaceutical AI is no longer compute. It is not even model architecture. It is data — but not in the…
BIO PA Partex.AI Reflections from the webinar “Real-World Data is Transforming Biopharma and Healthcare — How Do We… Date: (16 December 2025)